======= NFE2L3 =======
== Gene Information ==
* **Official Symbol**: NFE2L3
* **Official Name**: nuclear factor, erythroid 2 like 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9603|9603]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y4A8|Q9Y4A8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NFE2L3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NFE2L3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604135|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Activates erythroid-specific, globin gene expression.
|bZIP 1|
|bZIP Maf|
|transcription regulatory region sequence-specific DNA binding|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|transcription coactivator activity|
|transcription by RNA polymerase II|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|DNA-binding transcription factor activity|
|negative regulation of transcription by RNA polymerase II|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|organic cyclic compound biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|macromolecule biosynthetic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp287|HMS-I2 5μM R06 exp287]]|-2.03|
|[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.81|
|[[:results:exp111|R-DABN 8μM R03 exp111]]|1.97|
|[[:results:exp93|DABN racemic mixture R03 exp93]]|2.1|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.13|
|[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.17|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|2.2|
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.41|
|[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.89|
|[[:results:exp244|SB743921 0.001μM R05 exp244]]|3.33|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8183
* **Expression level (log2 read counts)**: 3.05
{{:chemogenomics:nalm6 dist.png?nolink |}}